If you are Long-term shareholder, you better not miss SunPower Corporation (SPWR) and Corcept Therapeutics Incorporated (CORT)

On Nov 11, Wood Patrick III, Director exercised an option 8,855 shares of SunPower Corporation (NASDAQ: SPWR), with the average selling price of the stock being $0.00 per share. The total amount realized from this exercised an option $0. A document was filed with the Securities and Exchange Commission to notify the public about the exercised an option of the shares.

In addition to that, Director – MCDANIEL THOMAS R exercised an option an extra 8,855 shares of this stock in a transaction that took place a day before, on Nov 11, with a share exercised an option at an average of $0.00 and a total of $0 was realized from this transaction. After the transaction, the Director – MCDANIEL THOMAS R was left with 8,971 shares of the company’s stock, which is currently worth around $0.0.

The recent price movement of SPWR means that it is now down by -53.30% from its 52-week high and 64.62% up against its 52-week low prices. Over the past one week, the price volatility of SPWR stands at 4.82% while the volatility over the past one month is 7.69%. The beta score for this stock is 2.18. A beta score below 1 means that the stock has a low volatility while above 1 signifies that a stock is highly volatile at that particular moment, a data that traders use to keep tabs on their investments.

The company on 10/30/2019 published its latest quarterly earnings, with the report showing that the company recorded -0.21 earnings per share (EPS) during that period. This report was above the expectations of analysts of -0.32 by 0.11. The revenue by the firm was 660.84M for the quarter.

The shares of SunPower Corporation (SPWR) dropped by -1.19%, leading to a loss of -$0.09 per share, and saw SPWR end the trading session at $7.49 on Friday 11/29/19. SPWR started the trading session at $7.52, before reaching a daily high of $7.645. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $7.41.

The trading volume on Friday stood at 2310930, which was below the stock’s 3-month average volume of 3.81 million shares, out of a total 88.03M shares. As the price of the stock dipped, the market valuation of the company dropped to 1.27 billion.

The shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) went down by -2.88% by the end of the recent trading session. This movement saw its price plunge to close at $12.83, which was lower than the previous closing price of $13.21. Over the past one week, the price of CORT has slipped by -1.08%, while it has recorded a loss of -10.90% over the past one month. Its three-month performance saw CORT gain 1.74% while its six-month performance saw it surge by 31.05%. The situation is different though over the past one year, as the stock price went down by -7.96%, while its year-to-date (YTD) price performance slipped by -3.97%. The stock price has gone up by +14.86% compared to its 90-day low, while it is down -26.60% compared to its 90-day high price.

Let’s take a look at its short, medium and long-term indicators. Composite Indicators shows that Trendspotter rated the stock as a Sell. In the short-term, the stock has a 20-day average volume of 1,421,340 shares, with the short-term indicators averagely rating the stock as a 50% Buy. A look at its medium-term indicators reveals that it has a 50-Day average volume of 971,870 shares and the indicators have an average rating of 50% Buy. The last indicators, the long-term see CORT stock with a 100-Day average volume of 822,301 shares, giving it an average rating of 50% Buy. A look at the general picture of all short, medium and long-term indicators leaves CORT with an average rating of 40% Buy.

Several brokerage firms sent out their reports CORT stock not long ago. In its report sent out on September 24, 2019, Jefferies lowered its ratings on CORT to a Buy. In an earlier report on September 06, 2019, H.C. Wainwright Initiated the stock to a Buy. B. Riley FBR meanwhile in its report on February 04, 2019 Downgrade its rating of the stock from a “Neutral” to “Neutral”.

In related news to the company’s stock, around 75.00% shares are being held by institutional investors. In a recent SEC filing, the company revealed that 216 institutions currently hold the CORT stock. In the last quarter, a 85,537,756 CORT shares were in the possession of institutions.